A PubMed-based narrative review was conducted to outline current mechanistic concepts of burn wound progression. Preclinical in vitro and in vivo evidence relevant to ON101 related pathways was summarized. In
parallel, we reviewed a retrospective case series of patients treated with ON101, including those with deep burn wounds without full-epithelialization for >1 weeks and those receiving burn scar surgeries.


Four patients receiving ON101 were identified across deep burn wound care (n=3) and post–scar-revision wound care (n=1) settings. In the deep burn wound group, early ON101 intervention was associated with timely healing and absence of hypertrophic scar formation during follow-up, suggesting potential benefit in supporting favorable scar remodeling. In the scar revision case, wound healing progressed without dehiscence or clinically significant scar-related complications.
Based on growing clinical evidence, ON101 is being explored in burn care beyond chronic wound management. Even after appropriate burn treatment, delayed healing may lead to hypertrophic scarring, impaired aesthetics, functional limitation, and increased healthcare burden. As an easy-to-use botanical topical cream, ON101 may offer a practical adjunctive option for acute burns, hard-to-heal burn wounds, and post-burn scar management by supporting timely healing, favorable scar outcomes, and preservation of mobility in joint-related areas.
Burn injuries trigger prolonged inflammation that may contribute to wound progression, delayed re-epithelialization, hypertrophic scar formation, and functional impairment, particularly in anatomically mobile areas. Timely topical intervention aimed at maintaining a favorable wound microenvironment may help support orderly healing progression, optimize scar remodeling, and preserve functional recovery. This study investigates the early application of ON101 in burn care, with a focus on supporting healing progression, favorable scar outcomes, and functional recovery.